These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

707 related items for PubMed ID: 16405544

  • 41. Quality of life and sugar and fiber intake in women with irritable bowel syndrome.
    Park HJ, Jarrett M, Heitkemper M.
    West J Nurs Res; 2010 Mar; 32(2):218-32. PubMed ID: 20040735
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Reports of "satisfactory relief" by IBS patients receiving usual medical care are confounded by baseline symptom severity and do not accurately reflect symptom improvement.
    Whitehead WE, Palsson OS, Levy RL, Feld AD, VonKorff M, Turner M.
    Am J Gastroenterol; 2006 May; 101(5):1057-65. PubMed ID: 16573774
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
    Dove LS, Lembo A, Randall CW, Fogel R, Andrae D, Davenport JM, McIntyre G, Almenoff JS, Covington PS.
    Gastroenterology; 2013 Aug; 145(2):329-38.e1. PubMed ID: 23583433
    [Abstract] [Full Text] [Related]

  • 49. Characteristics, diagnostic and symptom profile of patients receiving tegaserod in routine clinical practice in Canada.
    Bradette M, Wawer AR, Balshaw R, Kelly S, Barbeau M, Sambrook R.
    Can J Clin Pharmacol; 2007 Aug; 14(3):e291-300. PubMed ID: 18025544
    [Abstract] [Full Text] [Related]

  • 50. Effect of linaclotide on severe abdominal symptoms in patients with irritable bowel syndrome with constipation.
    Rao SS, Quigley EM, Shiff SJ, Lavins BJ, Kurtz CB, MacDougall JE, Currie MG, Johnston JM.
    Clin Gastroenterol Hepatol; 2014 Apr; 12(4):616-23. PubMed ID: 24075889
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Quality of life in patients with inflammatory bowel disease and irritable bowel syndrome differs between subjects recruited from clinic or the internet.
    Jones MP, Bratten J, Keefer L.
    Am J Gastroenterol; 2007 Oct; 102(10):2232-7. PubMed ID: 17680842
    [Abstract] [Full Text] [Related]

  • 53. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R, Nikfar S, Abdollahi M.
    Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Stability of irritable bowel syndrome using a Rome II-based classification.
    Williams RE, Black CL, Kim HY, Andrews EB, Mangel AW, Buda JJ, Cook SF.
    Aliment Pharmacol Ther; 2006 Jan 01; 23(1):197-205. PubMed ID: 16393298
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.